Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest Versant Venture Management, LLC Stock Portfolio

$103Million

Equity Portfolio Value
Last Reported on: 03 May, 2024

About Versant Venture Management, LLC and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $103.1 Millions as of 31 Mar, 2024.

The top stock holdings of Versant Venture Management, LLC are CRSP, SKYE, RPTX. The fund has invested 33% of it's portfolio in CRISPR THERAPEUTICS AG and 30.4% of portfolio in SKYE BIOSCIENCE, INC.

The fund managers got completely rid off RAYZEBIO, INC. stocks. They significantly reduced their stock positions in ADVERUM BIOTECHNOLOGIES, INC. (ADVM). Versant Venture Management, LLC opened new stock positions in SKYE BIOSCIENCE, INC. (SKYE).

New Buys

Ticker$ Bought
SKYE BIOSCIENCE, INC.31,400,500

New stocks bought by Versant Venture Management, LLC

Additions

No additions were made to existing positions by Versant Venture Management, LLC

Reductions

Ticker% Reduced
ADVERUM BIOTECHNOLOGIES, INC.0.00

Versant Venture Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
RAYZEBIO, INC.-320,683,000

Versant Venture Management, LLC got rid off the above stocks

Current Stock Holdings of Versant Venture Management, LLC

Last Reported on: 03 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ADVMADVERUM BIOTECHNOLOGIES, INC.6.95506,8227,166,460REDUCED0.00
ALGSALIGOS THERAPEUTICS, INC.2.202,320,3802,273,970UNCHANGED0.00
CRSPCRISPR THERAPEUTICS AG32.95498,55833,981,700UNCHANGED0.00
GRTSGRITSTONE ONCOLOGY, INC.8.873,561,1509,152,160UNCHANGED0.00
PASGPASSAGE BIO, INC.6.494,959,7706,695,690UNCHANGED0.00
RPTXREPARE THERAPEUTICS, INC.12.092,646,66012,465,800UNCHANGED0.00
SKYESKYE BIOSCIENCE, INC.30.452,007,70031,400,500NEW
RAYZEBIO, INC.0.000.000.00SOLD OFF-100